HighMark Wealth Management’s PhenomeX CELL Stock Holding History
Bought
Maintained
Sold
HighMark Wealth Management's CELL Position: Q4 2023 in Review
HighMark Wealth Management sold out of PhenomeX (CELL) in Q4 2023, closing a stake of 550 shares — an estimated $549 sold.
HighMark Wealth Management first reported a position in CELL in Q1 2022 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- HighMark Wealth Management reported no remaining PhenomeX position as of Q4 2023 after selling out during the quarter.
- HighMark Wealth Management sold 550 PhenomeX shares in Q4 2023, an estimated $549.
- HighMark Wealth Management first reported a position in PhenomeX in Q1 2022 and held it in 7 quarters.
- HighMark Wealth Management's PhenomeX position peaked at $4K in Q1 2022.
- 0 funds tracked by Wall St. Rank held PhenomeX as of Q4 2023.
Based on HighMark Wealth Management's 13F filing for Q4 2023, filed 23 Jan 2024.